Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

NCT05430854 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
155
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor Decision

Conditions

Interventions

Sponsor

Amgen